Mersana Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of MRSN for the last quarter is 2.29 M USD, and it's 75.20% lower compared to the previous quarter. The net income of Q2 24 is -24.27 M USD.